Compounds > gabexate
Page last updated: 2024-10-27

gabexate and Neutropenia

gabexate has been researched along with Neutropenia in 1 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Neutropenia: A decrease in the number of NEUTROPHILS found in the blood.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mitsuoka, H1
Kistler, EB1
Schmid-Schönbein, GW1

Other Studies

1 other study available for gabexate and Neutropenia

ArticleYear
Protease inhibition in the intestinal lumen: attenuation of systemic inflammation and early indicators of multiple organ failure in shock.
    Shock (Augusta, Ga.), 2002, Volume: 17, Issue:3

    Topics: Animals; Blood Pressure; Endopeptidases; Esters; Gabexate; Guanidines; Humans; In Vitro Techniques;

2002